Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Voyager Therapeutics Inc shares valued at $70,870 were sold by Ferguson Toby on Aug 18 ’25. At $3.73 per share, Ferguson Toby sold 19,000 shares. The insider’s holdings dropped to 138,914 shares worth approximately $0.61 million following the completion of this transaction.
Also, Ferguson Toby purchased 19,000 shares, netting a total of over 70,680 in proceeds.
Before that, Ferguson Toby had sold 10,086 shares from its account. In a trade valued at $34,595, the Chief Medical Officer traded Voyager Therapeutics Inc shares for $3.43 each. Upon closing the transaction, the insider’s holdings decreased to 10,086 shares, worth approximately $0.69 million.
As published in their initiating research note from Cantor Fitzgerald on January 10, 2025, Voyager Therapeutics Inc [VYGR] has been an Overweight. Analysts at Citigroup started covering the stock with ‘”a Buy”‘ outlook in a report released in early December. Earlier on October 16, 2024, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for VYGR stock.
Analyzing VYGR Stock Performance
On last trading session, Voyager Therapeutics Inc [NASDAQ: VYGR] rose 5.29% to $4.38. The stock’s lowest price that day was $4.15, but it reached a high of $4.47 in the same session. During the last five days, there has been a surge of approximately 12.89%. Over the course of the year, Voyager Therapeutics Inc shares have dropped approximately -29.24%. Shares of the company reached a 52-week high of $6.27 on 01/07/25 and a 52-week low of $2.64 on 05/30/25.
Support And Resistance Levels for Voyager Therapeutics Inc (VYGR)
According to the 24-hour chart, there is a support level at 4.20, which, if violated, would cause prices to drop to 4.01. In the upper region, resistance lies at 4.52. The next price resistance is at 4.65. RSI (Relative Strength Index) is 68.69 on the 14-day chart, showing neutral technical sentiment.
Is Voyager Therapeutics Inc subject to short interest?
Stocks of Voyager Therapeutics Inc saw a sharp steep in short interest on 2025-08-29 dropping by -0.27 million shares to 2.94 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 3.21 million shares. A decline of -9.17% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.74 of the overall float, the days-to-cover ratio (short ratio) decline to 3.74.
Which companies own the most shares of Voyager Therapeutics Inc (VYGR)?
In terms of Voyager Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 10 in the next 12 months, up nearly 140.38% from the previous closing price of $4.16. Analysts anticipate Voyager Therapeutics Inc stock to reach 10 by 2025, with the lowest price target being 10. In spite of this, 2 analysts ranked Voyager Therapeutics Inc stock as Buy at the end of 2025. On March 26, 2024, Guggenheim assigned a price target of “a Buy” to the stock and initiated coverage with a $22.
